A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo
3d agoen
From the article
Conditions : Vitiligo Interventions : Drug: MH004 1.0% Ointment; Drug: MH004 Placebo Ointment Sponsors : Minghui Pharmaceutical (Hangzhou) Ltd Not yet recruiting
Continue reading on clinicaltrials.gov

Comments
Sign in to join the conversation.
No comments yet. Be the first.